Capital International Investors
IDXX icon

Capital International Investors’s Idexx Laboratories IDXX Stock Holding History

Capital International Investors’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-321,140
Closed -$211M – 463
2021
Q4 		$211M Buy
321,140
+554
+0.2% +$348K 0.04% 264
2021
Q3 		$199M Buy
320,586
+1,844
+0.6% +$1.24M 0.05% 250
2021
Q2 		$201M Buy
318,742
+124,830
+64% +$68.9M 0.05% 248
2021
Q1 		$94.9M Buy
193,912
+936
+0.5% +$469K 0.02% 291
2020
Q4 		$96.5M Buy
192,976
+1,004
+0.5% +$449K 0.03% 283
2020
Q3 		$75.5M Sell
191,972
-43
-0% -$15.9K 0.02% 287
2020
Q2 		$63.4M Buy
192,015
+19,543
+11% +$5.66M 0.02% 291
2020
Q1 		$41.8M Buy
172,472
+93,975
+120% +$24.5M 0.02% 274
2019
Q4 		$20.5M Buy
78,497
+1,851
+2% +$488K 0.01% 319
2019
Q3 		$20.8M Buy
+76,646
New +$21.3M 0.01% 320

Other funds holding IDXX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fundsmith LLP
Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return

Capital International Investors's IDXX Position: Q1 2022 in Review

Capital International Investors sold out of Idexx Laboratories (IDXX) in Q1 2022, closing a stake of 321,140 shares — an estimated $211M sold.

Capital International Investors first reported a position in IDXX in Q3 2019 and held it in 10 quarters. The position peaked at $211M in Q4 2021. 1,033 funds tracked by Wall St. Rank hold IDXX as of Q1 2022.

  • Capital International Investors reported no remaining Idexx Laboratories position as of Q1 2022 after selling out during the quarter.
  • Capital International Investors sold 321,140 Idexx Laboratories shares in Q1 2022, an estimated $211M.
  • Capital International Investors first reported a position in Idexx Laboratories in Q3 2019 and held it in 10 quarters.
  • Capital International Investors's Idexx Laboratories position peaked at $211M in Q4 2021.
  • 1,033 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2022.

Based on Capital International Investors's 13F filing for Q1 2022, filed 16 May 2022.